Heading
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore assumenda asperiores distinctio est perferendis esse animi maiores dolor numquam nihil sint, et quae nobis harum consequuntur! Assumenda facere magnam nostrum?
Investing in innovation to transform COPD care
We invest in groundbreaking research and innovative treatments to transform the Chronic Obstructive Pulmonary Disease landscape. Traditional therapies for COPD mainly focus on relieving symptoms and do little to address the underlying biology. The treatment landscape for COPD is seeing significant change. The use of emerging biological drugs, initially approved for asthma, is encouraging, although only in sub-groups of people with COPD. Further research is ongoing, looking at many other pathways, to see if broader patient groups will also be able to benefit.
By applying scientific rigour to target our research efforts on untangling the complexities of the immune system, we hope to bring our expertise from pioneering monoclonals in oncology, neuroscience, ophthalmology, and other areas, to advance treatment for immune-mediated respiratory and other diseases.
Join us to alleviate this suffering by advancing treatments and breaking the stigma. Together, we can restore hope and dignity to those affected by this debilitating disease.
By applying scientific rigour to target our research efforts on untangling the complexities of the immune system, we hope to bring our expertise from pioneering monoclonals in oncology, neuroscience, ophthalmology, and other areas, to advance treatment for immune-mediated respiratory and other diseases.
Join us to alleviate this suffering by advancing treatments and breaking the stigma. Together, we can restore hope and dignity to those affected by this debilitating disease.
"Roche has more than 30 years of experience developing innovative treatments for respiratory diseases. We are committed to applying our expertise to understand the immune mechanisms that drive COPD, so that we can bring positive change for physicians, their patients, and health care systems."
Larry Tsai
Senior Vice President and Global Head of Immunology, Product Development
Heading
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore assumenda asperiores distinctio est perferendis esse animi maiores dolor numquam nihil sint, et quae nobis harum consequuntur! Assumenda facere magnam nostrum?
Make a difference in respiratory health
Our work in addressing Chronic Obstructive Pulmonary Disease is part of a long-term strategic commitment, providing a stable and exciting career opportunity for those looking to make a meaningful impact.
Here’s what we offer:
Here’s what we offer:
- Cutting-edge innovation: Be part of a team leading advancements in biologics for COPD treatment.
- A global platform: Work on an international scale, collaborating across markets to bring groundbreaking treatments to patients.
- A culture of excellence: Join a company known for its strong values, commitment to innovation, and investment in employee growth.
Employee Engagement
